Overview
Kaname Akamata practices in Tokyo, Japan. Akamata is rated as a Distinguished expert by MediFind in the treatment of Scleroderma. Their top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Localized Scleroderma, and Acute Interstitial Pneumonia.
Their clinical research consists of co-authoring 48 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 43 articles in the study of Scleroderma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- SclerodermaAkamata isDistinguished. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Akamata isDistinguished. Learn about Systemic Sclerosis (SSc).
- Experienced
- Acute Interstitial PneumoniaAkamata isExperienced. Learn about Acute Interstitial Pneumonia.
- FibromatosisAkamata isExperienced. Learn about Fibromatosis.
- Interstitial Lung DiseaseAkamata isExperienced. Learn about Interstitial Lung Disease.
- Localized SclerodermaAkamata isExperienced. Learn about Localized Scleroderma.
- NecrosisAkamata isExperienced. Learn about Necrosis.
- Pulmonary HypertensionAkamata isExperienced. Learn about Pulmonary Hypertension.